Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Alexandra, Hammer"'
Autor:
Alexandra Hammer
Publikováno v:
Ethnologia Fennica. 49:9-35
Organic agriculture aims at enabling sustainable food economies. But agricultural temporalities and practices do not necessarily align with demands and schedules posed by packers, processors, or retailers – a detachment that complicates the actors
Autor:
Alexandra Hammer
Publikováno v:
Zeitschrift für Volkskunde. 2021:105-107
Autor:
Alexandra Hammer, Manuela Matschuck, Renate Koppensteiner, Daniela Seidinger, Oliver Schlager, Sabine Steiner, Deddo Moertl
Publikováno v:
British Journal of Nutrition. 122:698-706
As only limited evidence is available for potential benefits of n-3 PUFA supplementation in patients with peripheral arterial disease (PAD), we studied the effects of 4 g n-3 PUFA on endothelial function and inflammatory markers. Seventy patients wit
Autor:
Alexander Niessner, M Todorovic, F Katsch, Patrick Sulzgruber, Hana Šinkovec, Niema Kazem, Felix Hofer, Georg Heinze, Georg Duftschmid, Alexandra Hammer, Walter Gall, Lorenz Koller
Publikováno v:
European Heart Journal. 41
Background Secondary prevention after acute coronary syndrome (ACS) mirrors a key position in the reduction of morbidity and mortality in this highly vulnerable patient population. Especially dual anti-platelet therapy (DAPT) – including aspirin pl
Autor:
F Katsch, Lorenz Koller, Hana Šinkovec, Alexander Niessner, Niema Kazem, Felix Hofer, Walter Gall, Georg Duftschmid, Alexandra Hammer, Georg Heinze, M Todorovic, Patrick Sulzgruber
Publikováno v:
European Heart Journal. 41
Background Secondary prevention after acute coronary syndrome (ACS) mirrors a key position in the reduction of morbidity and mortality in this highly vulnerable patient population. Especially cardiac rehabilitation proved to be one of the most benefi
Autor:
Georg Duftschmid, Walter Gall, Alexandra Hammer, Hana Šinkovec, F Katsch, Alexander Niessner, Niema Kazem, Felix Hofer, Lorenz Koller, M Todorovic, Patrick Sulzgruber, Georg Heinze
Publikováno v:
European Heart Journal. 41
Background Secondary prevention after acute coronary syndrome (ACS) mirrors a key position in the reduction of morbidity and mortality in this highly vulnerable patient population. Especially lipid lowering therapy – via high-intensity statins (ato
Autor:
Alexandra Hammer, Barbara Steinlechner, Lorenz Koller, Tatjana Fleck, Patrick Sulzgruber, Günther Laufer, Niema Kazem, Johann Wojta, Sebastian Schnaubelt, Alexander Niessner
Publikováno v:
European Heart Journal. 41
Background Recent guidelines state that in patients with surgical biological aortic valve replacement (AVR), the use of anti-platelet therapy is as a valid alternative to postoperative anticoagulation (AC) in the absence of a further indication for A
Autor:
Oliver Schlager, Alexandra Hammer, Aura Giurgea, Othmar Schuhfried, Veronika Fialka-Moser, Michael Gschwandtner, Renate Koppensteiner, Sabine Steiner
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 3334 (2012)
BACKROUND: Serum markers of inflammation and platelet activation are related to cardiovascular risk. Cardiovascular risk reduction is a major treatment goal in patients with peripheral arterial disease (PAD). Although current guidelines recommend sup
Externí odkaz:
https://doaj.org/article/6e62b77d88154ed4a852a3669b088d73
Autor:
Martin Huelsmann, Steffen Blum, Alexander Niessner, Patrick Sulzgruber, Alexandra Hammer, Niema Kazem, Lorenz Koller, J Wojta, Christian Hengstenberg
Publikováno v:
European Heart Journal. 40
Background Heart failure with reduce ejection fraction (HFrEF) constitutes a global health issue representing a prevalent clinical syndrome. While pro-inflammatory cytokines proved to have a pivotal role in the development and progression of HFrEF, l
Autor:
Alexandra, Hammer, Deddo, Moertl, Oliver, Schlager, Manuela, Matschuck, Daniela, Seidinger, Renate, Koppensteiner, Sabine, Steiner
Publikováno v:
The British journal of nutrition. 122(6)
As only limited evidence is available for potential benefits of n-3 PUFA supplementation in patients with peripheral arterial disease (PAD), we studied the effects of 4 g n-3 PUFA on endothelial function and inflammatory markers. Seventy patients wit